NULIBRY Trademark

Trademark Overview

On Tuesday, June 23, 2020, a trademark application was filed for NULIBRY with the United States Patent and Trademark Office. The USPTO has given the NULIBRY trademark a serial number of 90015984. The federal status of this trademark filing is REGISTERED as of Tuesday, October 19, 2021. This trademark is owned by Origin Biosciences, Inc.. The NULIBRY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of rare metabolic and neurological diseases
nulibry

General Information

Serial Number90015984
Word MarkNULIBRY
Filing DateTuesday, June 23, 2020
Status700 - REGISTERED
Status DateTuesday, October 19, 2021
Registration Number6531804
Registration DateTuesday, October 19, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 29, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of rare metabolic and neurological diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 21, 2020
Primary Code005
First Use Anywhere DateWednesday, March 31, 2021
First Use In Commerce DateWednesday, March 31, 2021

Trademark Owner History

Party NameSENTYNL THERAPEUTICS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressSOLANA BEACH, CA 92075
Party NameOrigin Biosciences, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBoston, MA 02116
Party NameOrigin Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02116
Party NameOrigin Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02116

Trademark Events

Event DateEvent Description
Thursday, June 16, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, June 16, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 16, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 16, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 16, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, April 20, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, October 19, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, September 14, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, September 13, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, August 25, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 24, 2021STATEMENT OF USE PROCESSING COMPLETE
Friday, August 20, 2021USE AMENDMENT FILED
Tuesday, August 24, 2021SOU EXTENSION 1 GRANTED
Friday, August 20, 2021SOU EXTENSION 1 FILED
Tuesday, August 24, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 20, 2021TEAS EXTENSION RECEIVED
Friday, August 20, 2021TEAS STATEMENT OF USE RECEIVED
Tuesday, February 23, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 29, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 29, 2020PUBLISHED FOR OPPOSITION
Wednesday, December 9, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, November 20, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 19, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 18, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 18, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 5, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 5, 2020NON-FINAL ACTION E-MAILED
Monday, October 5, 2020NON-FINAL ACTION WRITTEN
Friday, September 25, 2020ASSIGNED TO EXAMINER
Tuesday, July 21, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 26, 2020NEW APPLICATION ENTERED

Related Keywords

nulibry neurological diseases metabolic rare preparations treatment pharmaceutical